Public trial registry of the CCC-Munich

Trial 42756493CAN2002 Ragnar

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
42756493CAN2002 Ragnar
World
Full title
:

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- Other tumors
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Sylvie Lorenzen 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier